MyBlueDotsHedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing MyBlueDots5 months ago01 mins COPENHAGEN, Denmark & PALO ALTO, Calif.–(BUSINESS WIRE)–Glooko and Hedia launched their interoperable solution, combining connected care, remote patient monitoring, and digital therapeutics for diabetes. Post navigation Previous: Azafaros granted important regulatory designations and clearance by European authorities for global Phase 3 studies, to be initiated in 2025Next: BOSTON ONCOLOGY ARABIA and SPIMACO Partner to Localize Advanced Oral Oncology Treatments in Saudi Arabia
‘Master control switch’ protein that heightens neurodegenerative disease offers new treatment target MyBlueDots3 days ago 0
New findings reveal how the heart is organized from the earliest stages of embryonic development MyBlueDots3 days ago 0
Scholastic performance is a key concern for young cancer patients, study finds MyBlueDots3 days ago 0